Around 30 patients suffering from advanced melanoma cancer are being enrolled in a clinical trial in Cork, with early results indicating improved survival rates.
The trial involves a combination of two existing treatments.
Doctors are being encouraged to refer suitable patients for inclusion in the clinical trial which is being offered by Cork Cancer Research Centre at Cork University Hospital.
Scientists believe that by delivering an electrical impulse or shock directly to the tumour along with an immunotherapy drug called IPI and low dose chemotherapy survival rates will improve for advanced melanoma patients.
Doctors involved in the clinical trial believe the new treatment will be widely adopted and have described it as one of the first of it's kind in the world.